George Adams

George Adams

Net worth: 173 430 $ as of 31/05/2026

78 year
Health Technology
Commercial Services
Consumer Services

Profile

George Adams is Chairman at StimCell Energetics, Inc. since 2024.
Dr. Adams is Executive Chairman & Secretary at VentriPoint Diagnostics Ltd. since 2010.
Dr. Adams is Director at Cell MedX (Canada) Corp.
Dr. Adams is President at Hemo-Stat Ltd. since 1989.
Former roles include President, Chief Executive Officer & Director at ProMIS Neurosciences, Inc. from 2005 to 2010; President & Chief Executive Officer at University of Toronto Innovations Foundation from 1999 to 2004; President & Chief Executive Officer at Utah Innovation Fund; Chairman at Sernova Biotherapeutics, Inc. from 2009 to 2015; Program Director at The University of Ottawa Heart Institute; Partner at Corvita Corp., EIDP, Inc., Pfizer Inc., Boston Scientific Corp., World Heart Corp., and Baxter Corp.; Senior Scientist at The Canadian Red Cross Society; and President at Canadian Biomaterials Society.
Education includes undergraduate and graduate degrees from The University of Waterloo and a doctorate from McMaster University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
11/05/2026 1,864,839 ( 0.99% ) 173 430 $ 31/05/2026

George Adams active positions

CompaniesPositionStart
VENTRIPOINT DIAGNOSTICS LTD. Chairman 17/12/2019
STIMCELL ENERGETICS INC. Chairman 26/02/2024
Director/Board Member -
Hemo-Stat Ltd.
President 21/10/2009

Former positions of George Adams

CompaniesPositionEnd
PROMIS NEUROSCIENCES, INC. Chief Executive Officer 02/06/2010
Chief Executive Officer 01/01/2004
President -
Director/Board Member 18/10/2010
See the detail of George Adams's experience

Training of George Adams

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

33

1st degree connections

18

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies18

Health Technology

Process Industries

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Hemo-Stat Ltd.

Health Technology

Health Technology

Health Services

Commercial Services

Electronic Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!